Business Insider

ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform

CARLSBAD, Calif., Nov. 2, 2022 /PRNewswire/ -- ImpediMed Limited (ASX: IPD) reached a milestone of 500,000 patient tests performed with the SOZO® Digital Health Platform. With over 1,100 devices in ...
pix11

New Data Evaluating ImpediMed's SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of America Annual Scientific Meeting 2022

Bioimpedance Spectroscopy Distinguishes between Fluid Status in Individuals with and without Heart Failure Bioimpedance Spectroscopy Derived Arm-to-Leg R0_ratio as a Predictor of Increased ...
Business Insider

ImpediMed Announces Presentation at Heart Failure Society of America Annual Scientific Meeting That Demonstrates Utility of SOZO® Digital Health Platform for Heart Failure ...

CARLSBAD, Calif. and BRISBANE, Australia, Sept. 10, 2021 /PRNewswire/ -- ImpediMed Limited (ASX: IPD), a global medical technology company using bioimpedance spectroscopy (BIS) to generate powerful ...
WDAF-TV

National Accreditation Program for Breast Centers (NAPBC) Includes Bioimpedance Spectroscopy in Latest Breast Cancer Care Standards

CARLSBAD, Calif., Oct. 31, 2024 /PRNewswire/ -- ImpediMed, a leader in medical technologies to clinically monitor and manage fluid and body composition, today announced the National Accreditation ...
Fox2Now St. Louis

ImpediMed Announces Two Posters at Heart Failure Society of America Annual Scientific Meeting That Demonstrate Utility of SOZO® Digital Health Platform for Heart Failure Patients

Bioimpedance Spectroscopy Distinguishes between Fluid Status in Individuals with and without Heart Failure Bioimpedance Spectroscopy Derived Arm-to-Leg R0_ratio as a Predictor of Increased ...